Package 51655-109-52

Brand: doxazosin

Generic: doxazosin
NDC Package

Package Facts

Identity

Package NDC 51655-109-52
Digits Only 5165510952
Product NDC 51655-109
Description

30 TABLET in 1 BOTTLE, PLASTIC (51655-109-52)

Marketing

Marketing Status
Marketed Since 2022-08-19
Brand doxazosin
Generic doxazosin
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "48c3b853-1eef-73bd-e063-6294a90a9355", "openfda": {"unii": ["86P6PQK0MU"], "rxcui": ["197627"], "spl_set_id": ["f2b35586-d550-3fcb-e053-2995a90a3403"], "manufacturer_name": ["Northwind Health Company, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE, PLASTIC (51655-109-52)", "package_ndc": "51655-109-52", "marketing_start_date": "20220819"}], "brand_name": "Doxazosin", "product_id": "51655-109_48c3b853-1eef-73bd-e063-6294a90a9355", "dosage_form": "TABLET", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "51655-109", "generic_name": "Doxazosin", "labeler_name": "Northwind Health Company, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Doxazosin", "active_ingredients": [{"name": "DOXAZOSIN MESYLATE", "strength": "4 mg/1"}], "application_number": "ANDA202824", "marketing_category": "ANDA", "marketing_start_date": "20220819", "listing_expiration_date": "20271231"}